SEARCH

SEARCH BY CITATION

References

  • 1
    Clark L, Goodwin GM. State- and trait-related deficits in sustained attention in bipolar disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2004; 254: 6168.
  • 2
    Latalova K, Prasko J, Diveky T, Velartova H. Cognitive impairment in bipolar disorder. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2011;155: 1926.
  • 3
    Berk M, Kapczinski F, Andreazza AC et al. Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 2011; 35: 804817.
  • 4
    Berk M, Copolov D, Dean O et al. N-acetyl cysteine as a glutathione precursor for schizophrenia – a double-blind, randomized, placebo-controlled trial. Biol. Psychiatry 2008; 64: 361368.
  • 5
    Berk M, Copolov DL, Dean O et al. N-acetyl cysteine for depressive symptoms in bipolar disorder–a double-blind randomized placebo-controlled trial. Biol. Psychiatry 2008; 64: 468475.
  • 6
    Dean O, Giorlando F, Berk M. N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action. J. Psychiatry Neurosci. 2011; 36: 7886.